NanoViricides (NNVC) Stock: Buy, Sell, or Hold?
NNVC - NanoViricides Inc.
$1.02
0.00 (0.00%)
▲
5d:
-11.3%
30d:
-25.55%
90d:
-25.55%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 05, 2026
21d
Get Alerted When NNVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NNVC is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NNVC is down 11.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NNVC is currently trading at $1.02, which is considered oversold relative to its 30-day fair value range of $1.17 to $1.43.
Technical Outlook: Technically, NNVC is in a downtrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NNVC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+488.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NNVC is in a downtrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NNVC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.00 (+488.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.17 -
$1.43
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 488.2% below Wall St target ($6.00)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.17 -
$1.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.33
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.91
Wall Street Target
$6.00
(+488.2%)
Share & Embed Analysis
Last updated: September 13, 2026 9:27 AM ET
Data refreshes hourly during market hours. Next update: 10:27 AM
Data refreshes hourly during market hours. Next update: 10:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NNVC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 43 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$569 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$314 | 47 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$140 | 62 BUY |